In breast cancer, colony-stimulating factor 1 (CSF-1) was identified to promote metastatic potential leading to progression of the tumor to malignancy, and overexpression of CSF-1 is associated with poor prognosis [10, 11]. Here, CSF1 is linked to neoplasm.